Fairfield, Bush & Co’s iShares Biotechnology ETF IBB Stock Holding History

Fairfield, Bush & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	+1,223	New	+$210K	0.11%	117
2026 Q1	–	Sell	-1,353	Closed	-$228K	–	122
2025 Q4	$228K	Buy	+1,353	New	+$220K	0.12%	107
2024 Q1	–	Sell	-793	Closed	-$108K	–	263
2023 Q4	$108K	Buy	+793	New	+$96.8K	0.06%	144
2023 Q3	–	Sell	-118	Closed	-$15K	–	277
2023 Q2	$15K	Buy	+118	New	+$15.3K	﹤0.01%	288
2022 Q3	–	Sell	-159	Closed	-$19K	–	260
2022 Q2	$19K	Buy	+159	New	+$18.9K	0.01%	261

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Fairfield, Bush & Co's IBB Position: Q2 2026 in Review

Fairfield, Bush & Co opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,223 shares worth $233K. The stake represents 0.11% of the portfolio and ranks #117 among its holdings. This is a return to the name: Fairfield, Bush & Co previously reported a position in IBB as recently as Q4 2025.

Fairfield, Bush & Co first reported a position in IBB in Q2 2022 and has held it in 5 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Fairfield, Bush & Co held 1,223 shares of iShares Biotechnology ETF worth $233K as of Q2 2026.
iShares Biotechnology ETF was a new Fairfield, Bush & Co position in Q2 2026.
iShares Biotechnology ETF made up 0.11% of Fairfield, Bush & Co's portfolio in Q2 2026, its #117 holding.
Fairfield, Bush & Co first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 5 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Fairfield, Bush & Co's 13F filing for Q2 2026, filed 13 Aug 2026.